Eli Lilly's Stock Surge Sparks $1 Trillion Market Cap Speculation
Eli Lilly & Co.'s soaring stock performance has led Morgan Stanley analysts to speculate whether it could become the first non-"Magnificent Seven" US company to reach a market value of $1 trillion. The analysts raised their price target for the drugmaker, projecting a market capitalization of about $900 billion. Lilly's stock has surged 32% this year, driven by demand for its diabetes and obesity drugs. The company's market value recently surpassed that of Tesla Inc., and several analysts have raised their price targets following strong earnings results.